Robert Aspbury
Corporate Officer/Principal chez CERTARA, INC.
Fortune : 5 M $ au 30/04/2024
Postes actifs de Robert Aspbury
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CERTARA, INC. | Corporate Officer/Principal | 01/01/2020 | - |
Historique de carrière de Robert Aspbury
Anciens postes connus de Robert Aspbury
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| COVANCE INC. | Corporate Officer/Principal | 01/01/2003 | 01/03/2019 |
Formation de Robert Aspbury
| The University of Liverpool | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Royaume-Uni | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectorielle
| Technology Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CERTARA, INC. | Technology Services |
| Entreprise privées | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
- Bourse
- Insiders
- Robert Aspbury
- Expérience
